News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aegerion Pharmaceuticals, Inc. (AEGR) to Ring the NASDAQ Stock Market Closing Bell



1/22/2013 9:07:59 AM

ADVISORY, Jan. 22, 2013 (GLOBE NEWSWIRE) -- What: Aegerion Pharmaceuticals, Inc. [AEGR], a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases, will visit the NASDAQ MarketSite in Times Square to commemorate the recent FDA approval of its first drug, JUXTAPID™, for the treatment of homozygous familial hypercholesterolemia (HoFH).

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES